SEC Form 4 · accession 0001225208-17-017258
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wesley W Von Schack
Director
Period of report
Nov 9, 2017
Accepted (ET)
Nov 13, 2017 · 6:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 9, 2017 | S | 1,000 | $104.1501 | D | 39,306 | I | By Trust |
| Common StockF1 | Nov 9, 2017 | G | 2,000 | $0.00 | D | 37,306 | I | By Trust |
| Common Stock | holding | — | — | — | 2,622 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.